Our Pricing

How to Use Wegovy Pen First Time UK

Published on: June 03, 2026

Learning how to use wegovy pen first time uk can feel daunting, but with proper guidance from our UK pharmacist team, you'll master the technique confidently. Wegovy (semaglutide) is a once-weekly injection for weight management, and at Cured Pharmacy, we provide comprehensive support from your first dose onwards, with pens available from £79.00 following clinical assessment.

Understanding Your Wegovy Pen Before First Use

The Wegovy FlexTouch pen is a pre-filled, single-dose injector designed for subcutaneous administration. Each pen contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones regulating appetite and glucose metabolism [1]. The pen requires no manual loading or complex assembly — it's engineered for straightforward home use.

Your starting dose is 0.25mg once weekly, which gradually escalates over 16 weeks to the maintenance dose of 2.4mg [2]. This titration schedule, established in the STEP clinical programme, minimises gastrointestinal side effects whilst allowing your body to adapt. The pen's dose counter displays your prescribed amount clearly, and the injection mechanism is spring-loaded for consistent delivery.

Before your first injection, inspect the pen through the window. The solution should be clear and colourless. If you notice particles, discolouration, or cloudiness, do not use that pen and contact our pharmacy team on (+44) 116 4646009. Store unused pens in the refrigerator between 2°C and 8°C, but never freeze them. Once you've started using a pen, it can remain at room temperature (below 30°C) for up to 6 weeks.

Step-by-Step Wegovy Injection Technique for First-Time Users

Preparation is crucial for a comfortable first injection. Wash your hands thoroughly with soap and water, then gather your Wegovy pen, an alcohol wipe, and a sharps container. Remove the pen from the refrigerator 30 minutes before injecting to allow it to reach room temperature — cold injections can cause discomfort.

Select your injection site: the front of your thighs, your abdomen (at least 5cm away from your navel), or the outer area of your upper arms. Rotate sites weekly to prevent lipodystrophy, a condition where repeated injections in the same spot cause lumpy or pitted skin. Clean the chosen area with an alcohol wipe and allow it to dry completely.

Remove the pen cap by pulling it straight off. Attach a new NovoFine needle by pushing it straight onto the pen and twisting until secure. Remove both the outer and inner needle caps. Perform a flow check by turning the dose selector to the flow check symbol, holding the pen with the needle pointing upward, and pressing the dose button until a drop appears at the needle tip. This confirms the pen is working correctly.

Turn the dose selector to your prescribed dose (0.25mg for your first injection). Pinch a fold of skin at your injection site, insert the needle at a 90-degree angle using a quick, dart-like motion, then press and hold the dose button until the dose counter returns to zero. Continue holding for at least 6 seconds to ensure full dose delivery [3]. Withdraw the needle, dispose of it immediately in your sharps container, and apply gentle pressure to the injection site if needed.

Common First-Time Injection Concerns

Many patients worry about pain, but the NovoFine needles are ultra-thin (typically 4mm or 6mm in length), and most people report only mild pressure. If you experience significant discomfort, you may be injecting too quickly or the solution may be too cold. A small amount of bleeding or bruising at the injection site is normal and typically resolves within a few days.

If you see a drop of liquid on your skin after injection, it doesn't necessarily mean you've lost your dose. Small amounts of backflow can occur, but as long as you held the button for 6 seconds, you've received the prescribed amount. If you're uncertain whether you've received your full dose, do not inject again — contact our clinical team for guidance rather than risking a double dose.

Wegovy Dosing Schedule and Titration Protocol

The Wegovy dosing protocol follows a structured 16-week escalation designed by Novo Nordisk based on STEP trial data [2]. You'll begin with 0.25mg weekly for 4 weeks, then increase to 0.5mg for 4 weeks, followed by 1mg for 4 weeks, then 1.7mg for 4 weeks, before reaching the maintenance dose of 2.4mg.

This gradual titration significantly reduces the incidence of nausea, vomiting, and diarrhoea — the most commonly reported side effects in clinical trials [4]. In the STEP 1 trial, participants following this schedule achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. Rushing the dose escalation increases side effect risk without improving outcomes.

Set a consistent weekly injection day and time to maintain steady medication levels. If you miss a dose and it's been less than 5 days, inject as soon as you remember. If more than 5 days have passed, skip that dose and resume your regular schedule. Never double up to compensate for a missed injection, as this increases the risk of severe gastrointestinal side effects.

When to Contact Your Prescriber About Dose Adjustments

If you experience persistent nausea, vomiting more than once daily, or severe abdominal pain during dose escalation, contact your prescriber before taking your next injection. They may recommend staying at your current dose for an additional week before escalating. This flexibility is built into the protocol and doesn't compromise treatment effectiveness.

Some patients reach their weight loss goals before reaching the 2.4mg maintenance dose. Your UK prescriber will review your progress regularly and may adjust your target dose based on your individual response and tolerability. All prescription adjustments require clinical assessment — never alter your dose independently.

Managing Side Effects During Your First Weeks on Wegovy

Gastrointestinal side effects are most pronounced during the first 8 weeks as your body adapts to semaglutide. In clinical trials, nausea affected approximately 44% of participants, though most cases were mild to moderate and resolved within 4-8 weeks [4]. Eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce nausea intensity.

Constipation affects roughly 24% of Wegovy users and can be managed with increased water intake (aim for 2-3 litres daily), dietary fibre from vegetables and whole grains, and gentle physical activity [4]. If constipation persists beyond a week, speak with our pharmacy team about suitable over-the-counter remedies that won't interfere with your treatment.

Injection site reactions — redness, itching, or mild swelling — occur in about 5% of patients and typically resolve within 2-3 days [3]. Rotating injection sites weekly and ensuring the solution reaches room temperature before injecting minimises this risk. If you develop a spreading rash, significant swelling, or signs of infection, contact your prescriber immediately.

Wegovy Storage, Disposal, and Safety Precautions

Proper storage maintains medication efficacy and safety. Unused Wegovy pens must be refrigerated between 2°C and 8°C until first use. Never store pens in the freezer compartment or directly against freezer packs, as frozen semaglutide loses potency and cannot be used. Once you've removed the pen cap for your first injection, you can store the pen at room temperature (below 30°C) for up to 6 weeks, making it convenient for travel.

Always keep the pen cap on when not in use to protect the medication from light. If you're travelling, transport your pens in an insulated cool bag with ice packs (ensuring the pens don't touch the ice directly). For air travel, keep Wegovy in your hand luggage with your prescription or our pharmacy dispensing label, as hold luggage temperatures can fluctuate outside safe ranges.

Used needles pose a sharps injury risk and must never go in household rubbish. Our pharmacy can provide NHS-approved sharps containers free of charge. Once full, seal the container and return it to any UK pharmacy, GP surgery, or council waste facility offering sharps disposal services. Never attempt to recap used needles, as this is the leading cause of accidental needle-stick injuries.

When Wegovy Is Not Suitable

Wegovy is contraindicated if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [1]. It's also not recommended during pregnancy or breastfeeding, as semaglutide crosses the placental barrier. If you're planning pregnancy, discontinue Wegovy at least 2 months before conception attempts.

Patients with severe gastrointestinal disease, including gastroparesis or inflammatory bowel disease, may experience worsened symptoms on semaglutide. Your UK prescriber will review your full medical history during consultation to ensure Wegovy is appropriate for your individual circumstances. All prescription medications at Cured Pharmacy require clinical assessment by a UK-registered prescriber before dispensing.

How to Use Wegovy Pen First Time: Maximising Treatment Success

Clinical trial data shows that combining Wegovy with reduced-calorie nutrition and increased physical activity produces significantly greater weight loss than medication alone [2]. In the STEP 1 trial, participants received counselling on achieving a 500-calorie daily deficit and 150 minutes of weekly physical activity alongside semaglutide treatment.

Track your injection schedule using a calendar or smartphone reminder to maintain consistency. Document your injection sites to ensure proper rotation, and note any side effects or concerns to discuss with your prescriber at follow-up consultations. At Cured Pharmacy, our UK clinical team provides ongoing support throughout your treatment journey — you're never alone in managing your weight loss programme.

Realistic expectations support long-term success. Most patients begin noticing appetite reduction within the first 2-3 weeks, with measurable weight loss typically appearing by week 4-6. The average weight reduction in clinical trials was 14.9% over 68 weeks, but individual results vary based on adherence, lifestyle factors, and metabolic differences [2]. Your UK prescriber will schedule regular reviews to assess progress and adjust your treatment plan as needed.

Scientific References

1. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Novo Nordisk Limited. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy FlexTouch Pre-filled Pen: Instructions for Use. Novo Nordisk A/S. https://www.novonordisk.co.uk/patients/diabetes-care/wegovy.html [accessed 13 August 2026]
4. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.